Skip to main content
Equibles
MRAI logo

MRAI · Marpai, Inc.

Track MRAI — free

Use MRAI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about MRAI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.21 +0.02 (+0.91%) At close · Aug 14
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“management has determined that our liquidity condition raises substantial doubt about our ability to continue as a going concern through twelve months from the date these unaudited interim condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$59.29M
Shares
26.83M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.21 Open$2.21 Day$2.12–2.29 52W close$0.22–2.37 Avg vol 30d116K Short int90K · 0.3% float · 1.0d Short vol75% Last earningsNov 12, 2025 DataJun 2023–Aug 2026 Filing10-Q · Aug 13

Raw chart and full-history price indicators begin at the captured split on Jun 29, 2023; bars on opposite sides are not compared.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +177%
above
Price vs 50-day avg +71%
above
RSI (14) 64
neutral
MACD trend Negative
52-week position 93%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +34%
trailing
6-month return +453%
trailing
YTD return +250%
this year
Relative strength +439%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Accumulating
+1 funds added
Insider flow Accumulating
Net +$3.4K over 90 days · 0% sells
Short interest Rising
0.33% of float · ▲ +92.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Squeeze score 48
elevated · 0–100
Fundamentals
Weak
Revenue growth −36%
Y/Y
EPS growth +51%
Y/Y
Free cash flow $-7.8M
Balance sheet $19.3M
net debt
Quant / Vol
risk profile
Very High
Volatility 176%
annualized · 1-yr
Max drawdown −86%
past year
ATR 7.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+177% Bullish
Price vs 50-day avg
+71% Bullish
RSI (14)
64 Neutral
MACD trend
Negative Bearish
52-week position
93% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Accumulating
+1 funds added
Insider flow Accumulating
Net +$3.4K over 90 days · 0% sells
Short interest Rising
0.33% of float · ▲ +92.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $2 · 93% Range high $2
vs 200-day avg +177% vs 50-day avg +71%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Healthcare Plans — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MRAI
Marpai, Inc.
this stock
$59.29M +250.2% -35.8% — 0.3%
UNH
Unitedhealth Group Inc
 $360.59B +21.7% +11.8% — 1.7%
CVS
CVS HEALTH Corp
 $120.57B +18.5% +7.8% 24.9 1.5%
ELV
Elevance Health, Inc.
 $84.48B +11.3% +12.5% 17.2 2.6%
CI
Cigna Group
 $73.19B +0.0% +11.2% 11.5 1.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1
% held
0.1%
Net QoQ
+20.5K sh
Top holder
FNY Investment Advisers,…
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
89.6K
Days to cover
1.0d
Change
+43.0K sh
View
Short Volume
Short vol %
75%
As of
Aug 17, 2026
Short Total
View
Fails to Deliver
FTD shares
1.3K
Value
$2.9K
As of
Jul 24, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 13, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$3.4K
Buyers / Sellers
2 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$18.1M
Net income (FY)
$-16.6M
EPS diluted
$-0.95
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 13, 2026
This year
9
View
Proposed Sales
Value
$13.5K
Shares
15.0K
Filed
May 29, 2024
View
Earnings & Events
Earnings Calls
Last call
Nov 12, 2025
View

Performance

Raw-price comparisons begin at the captured split on Jun 29, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
MRAI +0.5% +33.9% +452.5% -0.9% +250.2%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY +0.1% +29.5% +438.7% -4.8% +236.4%
Key facts CIK 1844392 CUSIP 571354208 13F (30d) 2 filings 1 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)